Health Care Industry
Industry: Email Alert RSS FeedGenetic forms of intravenous ciprofloxacin gain approval.(News)
Skin & Allergy News, October, 2006 by Mechcatie, Elizabeth
Several generic versions of the intravenous formulation of the widely used fluoroquinolone ciprofloxacin have been approved by the Food and Drug Administration, as part of what the agency says is its effort to make lower-cost generic drugs more widely available.
- Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »
The generic formulations are versions of the trade formulation of Cipro IV, approved in 1991 and marketed by Bayer Corp. Ciprofloxacin injection is provided in a concentration of 10 mg/mL, and is packaged in 20-mL and 40-mL vials, and in a 120-mL pharmacy bulk package, according to a statement issued Aug. 28 by the FDA to ...
Read the rest of this article with a Free Trial at HighBeam Research.